112 related articles for article (PubMed ID: 21925763)
1. Role of positron emission tomography in management of sinonasal neoplasms--a single institution's experience.
Lamarre ED; Batra PS; Lorenz RR; Citardi MJ; Adelstein DJ; Srinivas SM; Scharpf J
Am J Otolaryngol; 2012; 33(3):289-95. PubMed ID: 21925763
[TBL] [Abstract][Full Text] [Related]
2. 18-FDG-PET in the initial staging of sinonasal malignancy.
Ramakrishnan VR; Lee JY; O'Malley BW; Palmer JN; Chiu AG
Laryngoscope; 2013 Dec; 123(12):2962-6. PubMed ID: 23877974
[TBL] [Abstract][Full Text] [Related]
3. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.
Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925
[TBL] [Abstract][Full Text] [Related]
4. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
Tan A; Adelstein DJ; Rybicki LA; Saxton JP; Esclamado RM; Wood BG; Lorenz RR; Strome M; Carroll MA
Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):435-40. PubMed ID: 17515501
[TBL] [Abstract][Full Text] [Related]
5. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT.
Nayak JV; Walvekar RR; Andrade RS; Daamen N; Lai SY; Argiris A; Smith RP; Heron DE; Ferris RL; Johnson JT; Branstetter BF
Laryngoscope; 2007 Dec; 117(12):2129-34. PubMed ID: 17921898
[TBL] [Abstract][Full Text] [Related]
6. Utility of (18)F-FDG PET-CT in staging and restaging of patients with malignant salivary gland tumours: a single-institutional experience.
Sharma P; Jain TK; Singh H; Suman SK; Faizi NA; Kumar R; Bal C; Malhotra A; Kumar R
Nucl Med Commun; 2013 Mar; 34(3):211-9. PubMed ID: 23353886
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography-computed tomography adds to the management of salivary gland malignancies.
Razfar A; Heron DE; Branstetter BF; Seethala RR; Ferris RL
Laryngoscope; 2010 Apr; 120(4):734-8. PubMed ID: 20213798
[TBL] [Abstract][Full Text] [Related]
8. 18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.
Troost EG; Vogel WV; Merkx MA; Slootweg PJ; Marres HA; Peeters WJ; Bussink J; van der Kogel AJ; Oyen WJ; Kaanders JH
J Nucl Med; 2007 May; 48(5):726-35. PubMed ID: 17475960
[TBL] [Abstract][Full Text] [Related]
9. The Role of Positron Emission Tomography for the Management of Sinonasal Malignancies: A Systematic Review.
El-Adem D; Yang N; Gudis DA
Am J Rhinol Allergy; 2023 Sep; 37(5):593-610. PubMed ID: 37229633
[TBL] [Abstract][Full Text] [Related]
10. Endobronchial ultrasonography for positron emission tomography and computed tomography-negative lymph node staging in non-small cell lung cancer.
Shingyoji M; Nakajima T; Yoshino M; Yoshida Y; Ashinuma H; Itakura M; Tatsumi K; Iizasa T
Ann Thorac Surg; 2014 Nov; 98(5):1762-7. PubMed ID: 25149044
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography/computerized tomography (PET/CT) scanning for preoperative staging of patients with oral/head and neck cancer.
Nahmias C; Carlson ER; Duncan LD; Blodgett TM; Kennedy J; Long MJ; Carr C; Hubner KF; Townsend DW
J Oral Maxillofac Surg; 2007 Dec; 65(12):2524-35. PubMed ID: 18022480
[TBL] [Abstract][Full Text] [Related]
12. Endobronchial ultrasound-guided transbronchial needle aspiration for systematic nodal staging of lung cancer in patients with N0 disease by computed tomography and integrated positron emission tomography-computed tomography.
Ong P; Grosu H; Eapen GA; Rodriguez M; Lazarus D; Ost D; Jimenez CA; Morice R; Bandi V; Tamara L; Cornwell L; Green L; Zhu A; Casal RF
Ann Am Thorac Soc; 2015 Mar; 12(3):415-9. PubMed ID: 25584815
[TBL] [Abstract][Full Text] [Related]
13. External ultrasonography of the neck does not add diagnostic value to integrated positron emission tomography-computed tomography (PET-CT) scanning in the diagnosis of cervical lymph node metastases in patients with esophageal carcinoma.
Blom RL; Vliegen RF; Schreurs WM; Belgers HJ; Stohr I; Oostenbrug LE; Sosef MN
Dis Esophagus; 2012 Aug; 25(6):555-9. PubMed ID: 22150869
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of positron emission tomography-directed management of the neck in node-positive head and neck cancer after organ preservation therapy.
Sjövall J; Chua B; Pryor D; Burmeister E; Foote MC; Panizza B; Burmeister BH; Porceddu SV
Oral Oncol; 2015 Mar; 51(3):260-6. PubMed ID: 25553622
[TBL] [Abstract][Full Text] [Related]
15. Lymph node metastasis in sinonasal squamous cell carcinoma treated with IMRT/3D-CRT.
Guan X; Wang X; Liu Y; Hu C; Zhu G
Oral Oncol; 2013 Jan; 49(1):60-5. PubMed ID: 22884302
[TBL] [Abstract][Full Text] [Related]
16. Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma.
Baker JJ; Meyers MO; Frank J; Amos KD; Stitzenberg KB; Ollila DW
Am J Surg; 2014 Apr; 207(4):549-54. PubMed ID: 24674829
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer.
Bannas P; Weber C; Adam G; Frenzel T; Derlin T; Mester J; Klutmann S
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):445-51. PubMed ID: 20832181
[TBL] [Abstract][Full Text] [Related]
18. Comparing staging by positron emission tomography with contrast-enhanced computed tomography and by pathology in head and neck squamous cell carcinoma.
Qualliotine JR; Mydlarz WK; Chan JY; Zhou X; Wang H; Agrawal N
J Laryngol Otol; 2015 Dec; 129(12):1213-9. PubMed ID: 26490394
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer.
Myers LL; Wax MK
J Otolaryngol; 1998 Dec; 27(6):342-7. PubMed ID: 9857320
[TBL] [Abstract][Full Text] [Related]
20. The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors.
Kauhanen S; Seppänen M; Ovaska J; Minn H; Bergman J; Korsoff P; Salmela P; Saltevo J; Sane T; Välimäki M; Nuutila P
Endocr Relat Cancer; 2009 Mar; 16(1):255-65. PubMed ID: 19088184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
